Use of circulating galactomannan screening for early diagnosis of invasive Aspergillosis in allogeneic stem cell transplant recipients

Journal of Infectious Diseases

Volumn 186, Issue 9, 2002, Pages 1297-1306

  Maertens, Johan ^a   Van Eldere, Johan ^a   Verhaegen, Jan ^a   Verbeken, Erik ^a   Verschakelen, Johny ^a   Boogaerts, Marc ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; FLUCONAZOLE; FLUCYTOSINE; GALACTOMANNAN; ITRACONAZOLE; NYSTATIN; PREDNISOLONE; STEROID; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FEVER; FUNGUS ISOLATION; HUMAN; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; SCREENING TEST; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANEMIA, APLASTIC; ASPERGILLOSIS; BIOLOGICAL MARKERS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MANNANS; MIDDLE AGED; NEOPLASMS; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036838257     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/343804     Document Type: Article

References (62)

1. Gratwohl A, Passweg J, Baidomero H, Hermans J. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EGBMT). Bone Marrow Transplant 1999;24:231-45.
2. Jantunen E, Ruutu P, Niskanen L, et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997;19:801-8.
3. Ninin E, Milpied N, Moreau P, et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001;33:41-7.
4. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001;32: 1319-24.
5. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608-15.
6. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis: Disease spectrum, treatment practices, and outcomes. 13 Aspergillus Study Group. Medicine 2000;79:250-60.
7. Lin S, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: Systematic review of the literature. Clin Infect Dis 2001;32:358-66.
8. Rinaldi MG. Problems in the diagnosis of invasive fungal diseases. Rev Infect Dis 1991;13:493-5.
9. Barth PJ, Rossberg C, Koch S, Ramaswamy A. Pulmonary aspergillosis in an unselected autopsy series. Pathol Res Pract 2000;196:73-80.
10. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32.
11. Von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: Early diagnosis improves survival. Respiration 1995;62:341-7.
12. Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycosis Study Group. N Engl J Med 1999;340:764-71.
13. Boogaerts M, Winston D, Bow E, et al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy: A randomized, controlled trial. Ann Intern Med 2001;135:412-22.
14. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72:101-11.
15. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989;86: 668-72.
16. Wingard JR, Kubilis P, Lee L, et al. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis 1999;29:1402-7.
17. Dasbach EJ, Davies GM, Teutsch SM. Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis 2000;31:1524-8.
18. Prentice HG, Kibbler CC, Prentice AG. Towards a targeted, risk-based, antifungal strategy in neutropenic patients. Br J Haematol 2000;110:273-84.
19. Denning DW. Early diagnosis of invasive aspergillosis. Lancet 2000;355: 423-4.
20. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985;157:611-4.
21. Rohrlich, P. Sarfati J, Mariani P, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: Early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996;15:232-7.
22. Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999;37:3223-8.
23. Sulahian A, Boutboui F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001;91:311-8.
24. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: A prospective validation. Blood 2001;97:1604-10.
25. Hughes WT, Armstrong D, Bodey GP, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1997;25:551-73.
26. Denning DW. Treatment of invasive aspergillosis. J Infect 1994;28(Suppl 1): 25-33.
27. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Clin Infect Dis 2002;34:7-14.
28. Chandrasekar PH, Alangaden G, Manavathu E. Aspergillus: An increasing problem in tertiary care hospitals [letter]? Clin Infect Dis 2000;30:984-5.
29. Wald A, Leisenring W, van Burik J, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997;175:1459-66.
30. Ribaud P, Chastang C, Latgé JP, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999;28:322-30.
31. VandenBergh MF, Verweij PE, Voss A. Epidemiology of nosocomial fungal infections: Invasive aspergillosis and the environment. Diagn Microbiol Infect Dis 1999;34:221-7.
32. Ho PL, Yuen KY. Aspergillosis in bone marrow transplant recipients. Crit Rev Oncol Hematol 2000;34:55-69.
33. Jantunen E, Ruutu P, Piilonen A, Volin L, Parkkali T, Ruutu T. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000;26:759-62.
34. Aisner J, Wiernik PH, Schimpff SC. Treatment of invasive aspergillosis: Relation of early diagnosis and treatment to response. Ann Intern Med 1977; 86:539-43.
35. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-805.
36. Vogeser M, Wanders A, Haas A, Ruckdeschel G. A four-year review of fatal aspergillosis. Eur J Clin Microbiol Infect Dis 1999;18:42-5.
37. Gerson SL, Talbot GH, Hurwitz S, Lusk EJ, Strom BL, Cassileth PA. Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1985;79:57-64.
38. O’Grady NP, Baric PS, Bartlett JG, et al. Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis 1998;26:1042-59.
39. Korones DN, Hussong MR, Gullace MA. Routine chest radiography of children with cancer hospitalised for fever and neutropenia: Is it really necessary? Cancer 1997;80:1160-4.
40. Pasmans HLM, Loosveld OJL, Schouten TC, Thunnissen F, van Engelshoven JM. Invasive aspergillosis in immunocompromised patients: Findings on plain films and (HR) CT. Eur J Radiol 1992;14:37-40.
41. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996;100:171-8.
42. Reichenberger F, Habicht J, Matt P, et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 1999;24:1195-9.
43. Denning DW, Marinus A, Cohen J, et al. An EORTC multicenter prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998;37:173-80.
44. Jantunen E, Piilonen A, Volin L, et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000;25:867-71.
45. de Pauw BE, Meis JF. Progress in fighting systemic fungal infections in haematological neoplasia. Support Care Cancer 1998;6:31-8.
46. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001;19:253-9.
47. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-47.
48. Brown MJ, Worthy SA, Flint JDA, Muller NL. Invasive aspergillosis in the immunocompromised host: Utility of computed tomography and bronchoalveolar lavage. Clin Radiol 1998;53:255-7.
49. Heussel CP, Kauczor HU, Heussel GE, et al. Pneumonia in febrile neutropenic patients and bone marrow and blood stem-cell transplant recipients: Use of high-resolution computed tomography. J Clin Oncol 1999;17:796-805.
50. Maschmeyer G. Pneumonia in febrile neutropenic patients: Radiologic diagnosis. Curr Opin Oncol 2001;13:229-35.
51. Hebart H, Löffler J, Meisner C, et al. Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis 2000;181:1713-9.
52. Williamson EC, Leeming JP, Palmer HM, et al. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction. Br J Haematol 2000;108:132-9.
53. Roger TR, Haynes KA, Barnes RA. Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet 1990;336:1210-3.
54. Talbot JH, Weiner MH, Gerson SL, Provencher M, Hurwitz S. Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: Validation of the Aspergillus fumigatus antigen radioimmunoassay. J Infect Dis 1987;155:12-27.
55. Hopwood V, Johnson EM, Cornish JM, Foot AB, Evans EG, Warnock DW. Use of the pastorex Aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J Clin Pathol 1995;48:210-3.
56. De Repentigny L, Kaufman L, Cole GT, Kruse D, Latge JP, Matthew RC. Immunodiagnosis of invasive fungal infections. J Med Vet Mycol 1994; 32:239-52.
57. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich ELISA to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995;33:497-500.
58. Verweij PE, Stynen D, Rijs AJMM, de Pauw BE, Hoogkamp-Korstanje JA, Meis JF. Sandwich enzyme-linked immunosorbent assay compared with pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995;33:1912-4.
59. Letscher-Bru V, Herbrecht R, Oprea C, et al. Aspergillus galactomannan ELISA in onco-hematologic patients [abstract J-842]. In: Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago, 22-25 September 2001). Chicago: American Society for Microbiology, 2001:386.
60. Donnelly JP. Infection in the neutropenic and hematopoietic stem cell transplant recipient. Curr Opin Infect Dis 2000;13:337-42.
61. Maertens J, Demuynck H, Verbeken EK, et al. Mucormycosis in allogeneic bone marrow transplant recipients: Report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999; 24:307-12.
62. Severens JL, Donnelly JP, Meis JFGM, De Vries Robbe PF, de Pauw BE, Verweij PE. Two strategies for managing invasive aspergillosis: A decision analysis. Clin Infect Dis 1997;25:1148-54.